An interventional study of Control Group and TECAR therapy in TECAR Therapy and Low Back Pain, sponsored by Cairo University. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-17.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn whether adding TECAR therapy to traditional physiotherapy is more effective than traditional physiotherapy alone for reducing pain and functional disability and improving physical performance in adults with chronic low back pain.
The main questions it aims to answer are:
Does adding TECAR therapy to traditional physiotherapy reduce pain intensity compared with traditional physiotherapy alone? Does adding TECAR therapy to traditional physiotherapy reduce functional disability? Does adding TECAR therapy improve core muscle endurance, back proprioception, back range of motion, and functional exercise capacity?
Participants will:
Receive 12 treatment sessions of either traditional physiotherapy with TECAR therapy or traditional physiotherapy alone.
Have their pain intensity and functional disability assessed before and after treatment.
Have their core muscle endurance, back proprioception, back range of motion, and functional exercise capacity assessed before and after treatment.
Chronic low back pain is a common musculoskeletal condition that can affect pain, daily activities, and physical function. Traditional physiotherapy is commonly used in the management of chronic low back pain; however, additional treatment approaches may be used to enhance treatment outcomes.
TECAR therapy is a non-invasive physical therapy modality that uses radiofrequency electromagnetic energy to deliver therapeutic effects to the treated tissues. It has been proposed as an adjunct to conventional physiotherapy for the management of musculoskeletal conditions.
The purpose of this clinical trial is to investigate whether adding TECAR therapy to traditional physiotherapy provides additional benefits compared with traditional physiotherapy alone in adults with chronic low back pain. The study will compare changes in clinical and physical performance outcomes between the two treatment approaches following the treatment period.
2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
This study's planned enrollment of 80 is above the median of 60 across 2,364 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Control Group
Device: TECAR therapy
Apply sham TECAR and physical therapy programmes, including core training exercises, myofascial release, and mobilisation exercises for three sessions per week for four weeks.
In addition to the programme given in the control group, the TECAR group, therapy was delivered using the TECAR device in resistive mode with a frequency of 500 kHz. A flexible, self-adhesive return electrode (10 cm × 18 cm) was placed on the abdomen as a reference electrode. The power output was gradually increased from approximately 30% to 60% of the device's maximum output (100 W), with adjustments based on patient-reported thermal feedback to ensure a consistent perception of mild to moderate warmth. Each quadrant of the lumbar region was treated for approximately 5 min, to 20 min per session
Pain Intensity Measured Using the Visual Analogue Scale (VAS)
Low back pain will be measured using the visual analogue scale (VAS) before and after the treatment. VAS is a scale ranging from 0 to 10 where 0 indicates no pain and 10 indicates severe pain.
Time frame: Baseline, after 1 week and after 12 weeks
Pain threshold measured using the pressure algometer.
Pain threshold will be measured before and after treatment using a pressure algometer.
Time frame: Baseline, 1 week and after 12 weeks
Back range of motion measured using BROM device.
Back range of motion will be measured using BROM device before and after the treament
Time frame: Baseline, 1 week and after 12 weeks
Functional disability measured using the Oswestry Disability Index
Functional disability will be measured using the Oswestry Disability Index (ODI). The ODI consists of 10 items, with each item scored from 0 to 5, yielding a total score ranging from 0 to 50. The total score can also be expressed as a percentage (0-100%), with higher scores indicating greater disability. Measurement will be done before and after the treatment.
Time frame: Baseline, 1 week and after 12 weeks
Quality of Life Measured Using the Short Form-36 Health Survey (SF-36)
Patient quality of life will be assessed using the Short Form-36 Health Survey (SF-36) before and after treatment. The SF-36 consists of 36 items covering eight domains of health-related quality of life. Scores are transformed to a 0-100 scale, with higher scores indicating better quality of life.
Time frame: Baseline, 1 week and after 12 weeks
Core Muscle Endurance Measured Using the McGill Core Endurance Test
Core muscle endurance will be assessed using the McGill Core Endurance Test. The test evaluates the endurance of the trunk musculature through four trunk endurance tests (trunk flexor, trunk extensor, and right and left lateral flexor endurance), with performance recorded as the duration (in seconds) that the participant is able to maintain the required test position. Higher durations indicate greater core muscle endurance.
Time frame: Baseline, 1 week and after 12 weeks
Back Proprioception Measured Using the Back Range of Motion (BROM) Device
Back proprioception will be assessed using the Back Range of Motion (BROM) device. Back joint position sense will be evaluated by measuring the absolute repositioning error, expressed in degrees, between the participant's target trunk position and the position reproduced after returning to the starting position. Lower repositioning error indicates better back proprioceptive accuracy.
Time frame: Baseline, 1 week and after 12 weeks
Aerobic Capacity Measured Using the 6-Minute Walk Test (6MWT)
Aerobic capacity will be assessed using the 6-Minute Walk Test (6MWT). The distance walked during the 6-minute test will be recorded in metres, with a greater distance indicating better functional exercise capacity.
Time frame: baseline, 1 week and after 12 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.